IP Verse

Kalhammer competitive analysis

Explore patent oppositions filed by Kalhammer against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026

Patent Number	Title	Applicant	Opposition Date
EP2588090	Pharmaceutical Oral Dosage Forms Comprising Dabigatran Etexilate And Its Pharmaceutically Acceptable Salts	KRKA	Jan 19, 2018
EP2682397	Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same	GILEAD SCIENCES	Jan 19, 2018
EP1993360	Solid Forms Of N-[2,4-Bis(1,1-Dimethylethyl)-5-Hydroxyphenyl]-1,4-Dihydro-4-Oxoquinoline-3-Carboxamide	VERTEX PHARMACEUTICALS	Nov 3, 2017
EP2841431	Dihydrate Of Benzothiophene Compound Or Of A Salt Thereof, And Process For Producing The Same	OTSUKA PHARMACEUTICAL	Sep 28, 2017
EP2398468	Pharmaceutical Compositions Comprising Prasugrel Base Or Its Pharmaceutically Acceptable Acid Addition Salts And Processes For Their Preparation	KRKA	Aug 29, 2017
EP2536724	Process For Preparing Entecavir And Its Intermediates	SCINOPHARM TAIWAN	Aug 23, 2017
EP1819323	Pharmaceutical Composition Containing An Anti-Nucleating Agent	MERCK & CO., INC.	Aug 14, 2017
EP2712617	Treatment Of Fibrosis Using Fxr Ligands	INTERCEPT PHARMACEUTICALS	Aug 2, 2017
EP2498762	Method For Preventing The Crystallisation Of Pharmaceuticals In A Polymer Film	LTS LOHMANN THERAPIE SYSTEME	Jun 7, 2017
EP1674107	Use Of Daptomycin	CUBIST PHARMACEUTICALS	May 16, 2017

Discover the latest PTAB cases involving Kalhammer, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Kalhammer with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
GEORG KALHAMMER/STEPHAN TEIPEL	15	-	-	-
CUBIST PHARMACEUTICALS	-	11	-	13
GILEAD SCIENCES	7	63	8	6
KRKA	37	21	-	-